Streamlining Collaboration and Development for Neglected Diseases Drug Discovery Using CDD Vault

webinar

Tue, 13 Jul 2021, 16:00 CEST (Berlin)

Dr. Kelly Bachovchin, Collaborative Drug Discovery, USA

Streamlining Collaboration and Development for Neglected Diseases Drug Discovery Using CDD Vault

We are happy to announce a guest speaker webinar by Kelly Bachovchin from our friends at Collaborative Drug Discovery. CDD provide a whole solution for today’s biological and chemical data needs, differentiated by ease-of-use and a strong focus on collaborative capabilities. Efforts to develop new drugs to treat neglected tropical diseases are limited and therefore rely on collaborations between academic and industrial institutions. Kelly will speak about how they help share up-to-date information and data — which is pertinent for these types of collaborations.

CDD Vault®, a cloud-based software, includes activity & registration, visualization, inventory, and ELN capabilities.  Researchers can archive, mine, and securely collaborate within CDD Vault.  Collaborative hypothesis generation and evaluation allow multiple perspectives for multi-parameter optimization.

CDD vault helps to streamline the drug discovery process, and Kelly will show this with a real world example. CDD, being a key player in modern state-of-the-art drug discovery, has contributed to many breakthroughs in various projects; should you be curious about A.I. integration in our discipline —  then an excellent talk on machine learning in drug discovery can be accessed here.

Current news

category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on
category
Events
Beyond the Flatland: sp³-Rich Fragments Unlock Novel Kinase Chemotypes: Free Webinar!
September 15, 2026 10:40 CEST
Kinases are among the most intensively pursued target families in drug discovery, yet the chemical matter screened against them remains surprisingly narrow. Conventional kinase-focused libraries are dominated by flat, heteroaromatic compounds, while saturated, three-dimensional molecules stay largely underexplored. That narrow structural diversity makes it harder to find genuinely novel chemotypes,...
Read on
LifeCheMyriads by Life Chemicals - Access now with our tools
August 31, 2026 09:39 CEST
LifeCheMyriads brings an actionable, novelty-focused universe of 53 billion on-demand synthesizable compounds directly into your workflow. Created by Life Chemicals, this collection was built from 210 in-house-validated reaction protocols and 20,000+ proprietary and commercially available building blocks. The result is a medicinal chemistry-driven catalog spanning more than 340 million unique...
Read on